Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation
BuTalag, I., Sarhan, A., Harira, M. (2020). Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation. EKB Journal Management System, 26(4), 574-581. doi: 10.21608/zumj.2019.13352.1239
Iman Suliman BuTalag; Abdel-Mageed Mohamoud Sarhan; Mervat Mohammed Harira. "Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation". EKB Journal Management System, 26, 4, 2020, 574-581. doi: 10.21608/zumj.2019.13352.1239
BuTalag, I., Sarhan, A., Harira, M. (2020). 'Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation', EKB Journal Management System, 26(4), pp. 574-581. doi: 10.21608/zumj.2019.13352.1239
BuTalag, I., Sarhan, A., Harira, M. Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation. EKB Journal Management System, 2020; 26(4): 574-581. doi: 10.21608/zumj.2019.13352.1239

Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation

Zagazig University Medical Journal
Article 6, Volume 26, Issue 4, July 2020, Page 574-581  XML PDF (1.25 MB)
Document Type: Original Article
DOI: 10.21608/zumj.2019.13352.1239
View on SCiNiTO View on SCiNiTO
Authors
Iman Suliman BuTalag email 1; Abdel-Mageed Mohamoud Sarhan2; Mervat Mohammed Harira3
1Department of Obstetrics & Gynecology, Faculty of Medicine - Benghazi University, Libya
2Professor and Head of obstetrics and Gynaecology Faculty of Medicine - Zagazig University
3Lecturer of obstetrics and Gynaecology, Faculty of Medicine - Zagazig University
Abstract
Background: Many patients develop excessive response for gonadotropin stimulation through controlled ovarian stimulation (COS) cycle over the years, there was an increase in incidence of ovarian hyperstimulation syndrome (OHSS) which represents an important medical problem for the clinicians. Objectives: to compare GnRHa and hCG as ovulation trigger in patients with PCOS after controlled ovarian stimulation by estimation of ovulation rate and rate of clinical pregnancy in studied group and detect efficacy in preventing or reducing incidence of OHSS. Patients & Methods: This prospective study was carried out in the unit of Cytogenetic and Endoscopy in department of Obstetrics and Gynecology in Zagazig university hospital during the period from September 2017 to January 2018 where 52 subfertile women with anovulatory PCOS. Results: showed that there is no significant difference in the overall ovulation rate. The average rate of ovulation was 38 (33.04%) and 30 (26.06 %) in GnRHa and hCG groups. The OHSS incidence was higher in hCG group than the GnRHa group. Conclusions: hCG was the gold standard for complete oocyte maturation, the new agent seems to be GnRHa with its potential advantages over hCG trigger in OHSS reduction.
Keywords
gonadotropin; PCOs; Trigger of Ovulation
Statistics
Article View: 291
PDF Download: 267